Department of Urology Grand Rounds: Hiroko Miyagi, MD

The University of Florida Department of Urology
invites you to attend Grand Rounds:

Wednesday, June 10, 2020 7:00 – 8:00 AM
Zoom Meeting ID 920 5213 3171

Metastatic Renal Cell Carcinoma”

doctor miayagi is wearing her white doctors coat with dark scoop neck shirt. She has long dark hair.

Presenter: Hiroko Miyagi, MD

Learning Objectives:
Upon completion of this activity, participants should be able to:

  1. Review risk categorization for metastatic renal cell carcinoma
  2. Define the standard of care for advanced, unresectable renal cell carcinoma
  3. Understand the background of systemic therapy for metastatic renal cell carcinoma
  4. Understand the impact of systemic therapy on survival of metastatic renal cell carcinoma
  5. Understand the challenges of systemic therapy

Target Audience:
Urologists, Residents, Nurses, Physician Assistants, and Staff

The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Florida College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Department of Urology within the University of Florida’s College of Medicine is hosting
this free event which is internally supported.

Contact Information:
If you have any questions please feel free to contact Stephanie Stenner at

Dr. Miyagi has disclosed that she has no relevant financial relationships. Dr. Vincent Bird, Planning Committee, is a consultant for Boston Scientific. No one else in a position to control content has any financial relationship to disclose.

Section Number: 0142

logo that reads uf college of medicine department of urology university of Florida. The letters are in dark blue and there is dark orange vertical line between the UF and the reset of the words.


Florida’s Leading Academic Urology Program

Rated as High Performing Urology Program

Rated as High Performing in Prostate Cancer Surgery